MedPath
HSA Approval

CITANEST OCTAPRESSIN INJECTION

SIN06175P

CITANEST OCTAPRESSIN INJECTION

CITANEST OCTAPRESSIN INJECTION

May 3, 1991

DENTSPLY (SINGAPORE) PTE. LTD.

DENTSPLY (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDENTSPLY (SINGAPORE) PTE. LTD.
Licence HolderDENTSPLY (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

BUCCAL

Medical Information

N01BB04

prilocaine

Manufacturer Information

DENTSPLY (SINGAPORE) PTE. LTD.

ASTRA PHARMACEUTICALS PTY LTD

Active Ingredients

PRILOCAINE HCl

66 mg/2.2 ml

Prilocaine

FELYPRESSIN

0.066 iu/2.2 ml

Felypressin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CITANEST OCTAPRESSIN INJECTION - HSA Approval | MedPath